Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood

被引:26
作者
Hagiwara, E
Sacks, T
LeitmanKlinman, SF
Klinman, DM
机构
[1] US FDA,CTR BIOL EVALUAT & RES,DIV VIRAL PROD,LAB RETROVIRAL RES,BETHESDA,MD 20892
[2] NIH,CTR CLIN,DEPT TRANSFUS MED,BETHESDA,MD 20892
关键词
D O I
10.1089/aid.1996.12.127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A selective decrease in type 1 cytokine secretion by in vitro stimulated peripheral blood cells is reportedly associated with disease progression in HIV-infected individuals, To examine whether a similar change in cytokine secretion occurs under physiologic conditions in vivo, sensitive and specific ELIspot assays were used to compare the phenotype and frequency of PBMC spontaneously producing interleukin (IL)-2, IL-4, IL-10, and interferon-gamma (IFN-gamma) in 83 HIV-infected subjects and 60 normal controls, Phenotypic analysis of freshly isolated cytokine-secreting cells showed that T cells were the primary source of IL-2, IL-4, and IFN-gamma while CD14(+) macrophages/monocytes were the dominant source of IL-10 in vivo, The number of peripheral blood mononuclear cells (PBMC) spontaneously secreting both type 1 and type 2 cytokines was significantly reduced in HIV-infected patients versus controls, The magnitude of this decrease did not correlate with disease severity, Changes in IL-2-secreting cell number correlated with CD4 count, while changes in the frequency of IFN-gamma-secreting cells correlated with disease duration, These findings do not support the contention that a selective reduction in type 1 cytokine production correlates with disease progression.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 44 条
[1]  
AKRIDGE RE, 1994, J IMMUNOL, V153, P5782
[2]  
AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447
[3]   TH1 AND TH2 CYTOKINE PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-INFECTED PATIENTS [J].
BARCELLINI, W ;
RIZZARDI, GP ;
BORGHI, MO ;
FAIN, C ;
LAZZARIN, A ;
MERONI, PL .
AIDS, 1994, 8 (06) :757-762
[4]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[5]  
BREEN EC, 1990, J IMMUNOL, V144, P480
[6]   IMPAIRED INTERLEUKIN-12 PRODUCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
CHEHIMI, J ;
STARR, SE ;
FRANK, I ;
DANDREA, A ;
MA, XJ ;
MACGREGOR, RR ;
SENNELIER, J ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1361-1366
[7]   RESTORATION OF HIV-SPECIFIC CELL-MEDIATED IMMUNE-RESPONSES BY INTERLEUKIN-12 IN-VITRO [J].
CLERICI, M ;
LUCEY, DR ;
BERZOFSKY, JA ;
PINTO, LA ;
WYNN, TA ;
BLATT, SP ;
DOLAN, MJ ;
HENDRIX, CW ;
WOLF, SF ;
SHEARER, GM .
SCIENCE, 1993, 262 (5140) :1721-1724
[8]   THE TH1-TH2 HYPOTHESIS OF HIV-INFECTION - NEW INSIGHTS [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1994, 15 (12) :575-581
[9]   ROLE OF INTERLEUKIN-10 IN T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC INDIVIDUALS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
CLERICI, M ;
WYNN, TA ;
BERZOFSKY, JA ;
BLATT, SP ;
HENDRIX, CW ;
SHER, A ;
COFFMAN, RL ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :768-775
[10]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110